Oppenheimer & Co’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.15M | Sell |
11,330
-40
| -0.4% | -$7.52K | 0.02% | 622 |
|
|
2026
Q1 | $2.24M | Buy |
+11,370
| New | +$2.19M | 0.03% | 553 |
|
|
2025
Q4 | – | Sell |
-14,869
| Closed | -$2.28M | – | 1577 |
|
|
2025
Q3 | $2.28M | Buy |
14,869
+1,028
| +7% | +$156K | 0.03% | 560 |
|
|
2025
Q2 | $1.93M | Buy |
13,841
+1,938
| +16% | +$272K | 0.03% | 585 |
|
|
2025
Q1 | $1.75M | Sell |
11,903
-60
| -0.5% | -$8.68K | 0.03% | 583 |
|
|
2024
Q4 | $1.57M | Buy |
11,963
+681
| +6% | +$95.3K | 0.02% | 630 |
|
|
2024
Q3 | $1.76M | Buy |
11,282
+2,999
| +36% | +$484K | 0.03% | 597 |
|
|
2024
Q2 | $1.29M | Sell |
8,283
-851
| -9% | -$128K | 0.02% | 675 |
|
|
2024
Q1 | $1.24M | Buy |
9,134
+847
| +10% | +$112K | 0.02% | 664 |
|
|
2023
Q4 | $1.12M | Buy |
8,287
+1,075
| +15% | +$140K | 0.02% | 671 |
|
|
2023
Q3 | $977K | Buy |
7,212
+2,459
| +52% | +$336K | 0.02% | 685 |
|
|
2023
Q2 | $680K | Sell |
4,753
-458
| -9% | -$67.4K | 0.01% | 859 |
|
|
2023
Q1 | $723K | Sell |
5,211
-382
| -7% | -$51.4K | 0.02% | 811 |
|
|
2022
Q4 | $758K | Buy |
5,593
+83
| +2% | +$10.4K | 0.02% | 772 |
|
|
2022
Q3 | $604K | Sell |
5,510
-1,912
| -26% | -$243K | 0.01% | 823 |
|
|
2022
Q2 | $980K | Buy |
7,422
+1,121
| +18% | +$147K | 0.02% | 691 |
|
|
2022
Q1 | $836K | Buy |
6,301
+101
| +2% | +$12.1K | 0.02% | 811 |
|
|
2021
Q4 | $722K | Buy |
6,200
+148
| +2% | +$17.4K | 0.01% | 905 |
|
|
2021
Q3 | $727K | Sell |
6,052
-1,221
| -17% | -$142K | 0.01% | 865 |
|
|
2021
Q2 | $872K | Sell |
7,273
-5,120
| -41% | -$562K | 0.02% | 804 |
|
|
2021
Q1 | $1.23M | Buy |
12,393
+20
| +0.2% | +$2.01K | 0.02% | 638 |
|
|
2020
Q4 | $1.24M | Sell |
12,373
-1,697
| -12% | -$180K | 0.03% | 577 |
|
|
2020
Q3 | $1.54M | Buy |
14,070
+6,801
| +94% | +$756K | 0.04% | 451 |
|
|
2020
Q2 | $768K | Buy |
7,269
+3,143
| +76% | +$325K | 0.02% | 673 |
|
|
2020
Q1 | $368K | Sell |
4,126
-8,109
| -66% | -$763K | 0.01% | 835 |
|
|
2019
Q4 | $1.22M | Sell |
12,235
-1,073
| -8% | -$101K | 0.03% | 556 |
|
|
2019
Q3 | $1.19M | Sell |
13,308
-169
| -1% | -$14.7K | 0.03% | 542 |
|
|
2019
Q2 | $1.11M | Sell |
13,477
-527
| -4% | -$41.3K | 0.03% | 559 |
|
|
2019
Q1 | $1.13M | Buy |
14,004
+223
| +2% | +$17.6K | 0.03% | 555 |
|
|
2018
Q4 | $1.05M | Sell |
13,781
-4,672
| -25% | -$365K | 0.03% | 525 |
|
|
2018
Q3 | $1.46M | Sell |
18,453
-363
| -2% | -$27.5K | 0.04% | 482 |
|
|
2018
Q2 | $1.32M | Buy |
18,816
+647
| +4% | +$46.5K | 0.04% | 499 |
|
|
2018
Q1 | $1.27M | Buy |
18,169
+3,428
| +23% | +$237K | 0.03% | 528 |
|
|
2017
Q4 | $1.02M | Buy |
14,741
+6,634
| +82% | +$447K | 0.03% | 606 |
|
|
2017
Q3 | $550K | Buy |
8,107
+1,205
| +17% | +$76.1K | 0.01% | 813 |
|
|
2017
Q2 | $470K | Sell |
6,902
-2,601
| -27% | -$170K | 0.01% | 851 |
|
|
2017
Q1 | $592K | Buy |
9,503
+4,626
| +95% | +$269K | 0.02% | 741 |
|
|
2016
Q4 | $267K | Sell |
4,877
-14,859
| -75% | -$844K | 0.01% | 1046 |
|
|
2016
Q3 | $1.3M | Buy |
19,736
+4,745
| +32% | +$310K | 0.04% | 502 |
|
|
2016
Q2 | $906K | Buy |
14,991
+7,877
| +111% | +$458K | 0.03% | 577 |
|
|
2016
Q1 | $400K | Buy |
7,114
+317
| +5% | +$19K | 0.01% | 833 |
|
|
2015
Q4 | $462K | Sell |
6,797
-912
| -12% | -$59.8K | 0.01% | 788 |
|
|
2015
Q3 | $491K | Buy |
7,709
+2,443
| +46% | +$161K | 0.01% | 813 |
|
|
2015
Q2 | $336K | Sell |
5,266
-220
| -4% | -$15.1K | 0.01% | 1051 |
|
|
2015
Q1 | $376K | Buy |
5,486
+327
| +6% | +$22.7K | 0.01% | 1008 |
|
|
2014
Q4 | $363K | Sell |
5,159
-366
| -7% | -$26.2K | 0.01% | 953 |
|
|
2014
Q3 | $395K | Sell |
5,525
-15,918
| -74% | -$1.17M | 0.01% | 944 |
|
|
2014
Q2 | $1.59M | Sell |
21,443
-9,551
| -31% | -$690K | 0.05% | 444 |
|
|
2014
Q1 | $2.01M | Sell |
30,994
-4,460
| -13% | -$288K | 0.06% | 378 |
|
|
2013
Q4 | $2.1M | Sell |
35,454
-10,408
| -23% | -$565K | 0.07% | 340 |
|
|
2013
Q3 | $2.38M | Buy |
45,862
+4,140
| +10% | +$208K | 0.08% | 291 |
|
|
2013
Q2 | $1.97M | Buy |
+41,722
| New | +$2.12M | 0.08% | 310 |
|
Other funds holding AZN
EP
IA
Oppenheimer & Co's AZN Position: Q2 2026 in Review
Oppenheimer & Co reduced its AstraZeneca (AZN) stake by 0.35% in Q2 2026, selling an estimated $7.52K and leaving 11,330 shares worth $2.15M. The position accounts for 0.02% of the portfolio, ranked #622.
Oppenheimer & Co first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.38M in Q3 2013. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Oppenheimer & Co held 11,330 shares of AstraZeneca worth $2.15M as of Q2 2026.
- Oppenheimer & Co sold 40 AstraZeneca shares in Q2 2026, an estimated $7.52K.
- AstraZeneca made up 0.02% of Oppenheimer & Co's portfolio in Q2 2026, its #622 holding.
- Oppenheimer & Co first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- Oppenheimer & Co's AstraZeneca position peaked at $2.38M in Q3 2013.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.